483 Boehringer Ingelheim Fremont Aug 2018

483 Boehringer Ingelheim Fremont Aug 2018

Anita Narula FDA, Marcus Yambot FDA$119.00 - Available Now

FDA investigators audited the Boehringer Ingelheim Fremont - Fremont, CA, United States facility and issued inspectional observations (via FDA 483) on 24 Aug 2018.

Product details

  • Category: Human Drugs / Medical Devices & Rad Health
  • Inspection end: 24 Aug 2018
  • Location: Fremont, United States
  • FEI: 3005925062
Add To Cart